These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1535212)

  • 1. Reducing the cardiotoxicity of the anthracyclines.
    Carlson RW
    Oncology (Williston Park); 1992 Jun; 6(6):95-100, 104, 107, discussion 107-8. PubMed ID: 1535212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiotoxicity of anthracyclines].
    Ferrière M; Donadio D; Ramirez R
    Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():53-8. PubMed ID: 8215791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and non-invasive assessment of anthracycline cardiotoxicity: perspectives on myocardial protection.
    Mortensen SA; Aabo K; Jonsson T; Baandrup U
    Int J Clin Pharmacol Res; 1986; 6(2):137-50. PubMed ID: 3459718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of anthracycline-induced cardiotoxicity.
    Meinardi MT; van der Graaf WT; van Veldhuisen DJ; Gietema JA; de Vries EG; Sleijfer DT
    Cancer Treat Rev; 1999 Aug; 25(4):237-47. PubMed ID: 10448132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group.
    Steinherz LJ; Graham T; Hurwitz R; Sondheimer HM; Schwartz RG; Shaffer EM; Sandor G; Benson L; Williams R
    Pediatrics; 1992 May; 89(5 Pt 1):942-9. PubMed ID: 1579408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiotoxicity of anthracyclines].
    Laurent S; Colbert N; Izrael V; Motte G
    Ann Med Interne (Paris); 1984; 135(6):464-72. PubMed ID: 6391323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A historical perspective of anthracycline cardiotoxicity.
    Ewer MS; Von Hoff DD; Benjamin RS
    Heart Fail Clin; 2011 Jul; 7(3):363-72. PubMed ID: 21749888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anthracyclines and the heart].
    Mazzarello GP; Morra L
    Recenti Prog Med; 1998 Sep; 89(9):459-64. PubMed ID: 9796378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines.
    Pouillart P
    Cancer Treat Rev; 2004 Nov; 30(7):643-50. PubMed ID: 15531396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthracycline cardiotoxicity in long-term survivors of childhood cancer.
    Scully RE; Lipshultz SE
    Cardiovasc Toxicol; 2007; 7(2):122-8. PubMed ID: 17652816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiotoxicity of anthracycline].
    Wojtukiewicz MZ; Omyła J; Kozłowski L; Szynaka B
    Postepy Hig Med Dosw; 2000; 54(4):467-85. PubMed ID: 11016267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion].
    Orditura M; De Vita F; Ciaramella F; Catalano G
    Ann Ital Med Int; 1994; 9(4):243-8. PubMed ID: 7893575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
    Jensen BV
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring for anthracycline cardiotoxicity.
    Lipshultz SE; Sanders SP; Goorin AM; Krischer JP; Sallan SE; Colan SD
    Pediatrics; 1994 Mar; 93(3):433-7. PubMed ID: 7818624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline-induced cardiomyopathy.
    Keefe DL
    Semin Oncol; 2001 Aug; 28(4 Suppl 12):2-7. PubMed ID: 11552224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of cardiotoxicity induced by anthracyclines.
    Elliott P
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity.
    Jones RL
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1311-7. PubMed ID: 19018683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac toxicity in cancer therapy].
    Łacko A; Włodarska I; Zymliński R; Mazur G; Wróbel T; Gisterek I
    Pol Merkur Lekarski; 2002 Jul; 13(73):79-85. PubMed ID: 12362515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.